Cargando…
Salvage therapy for relapsed testicular cancer
Autores principales: | Adra, Nabil, Einhorn, Lawrence H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642471/ https://www.ncbi.nlm.nih.gov/pubmed/29050196 http://dx.doi.org/10.18632/oncotarget.20573 |
Ejemplares similares
-
Salvage therapy for relapsed testicular cancer
por: Adra, Nabil, et al.
Publicado: (2017) -
Adverse Health Outcomes Among US Testicular Cancer Survivors After Cisplatin-Based Chemotherapy vs Surgical Management
por: Agrawal, Vaibhav, et al.
Publicado: (2019) -
The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey
por: Al-Ezzi, Esmail M., et al.
Publicado: (2023) -
ESHAP salvage therapy for relapsed or refractory non-Hodgkin's lymphoma.
por: Choi, Chul Won, et al.
Publicado: (2002) -
Ultrasound heterogeneity as an indicator of testicular salvage in testicular torsion: A single center experience
por: Hasan, Omran, et al.
Publicado: (2022)